Landry D W, Oliver J A
Department of Medicine, College of Physicians & Surgeons, Columbia University, New York 10032.
J Clin Invest. 1992 Jun;89(6):2071-4. doi: 10.1172/JCI115820.
Endotoxemia causes hypotension characterized by vasodilation and resistance to vasopressor agents. The molecular mechanisms responsible for these changes are unclear. The ATP-regulated K+ (K+ATP) channel has recently been found to be an important modulator of vascular smooth muscle tone which may transduce local metabolic changes into alterations of vascular flow. We report here that in endotoxic hypotension, the sulfonylurea glyburide, a specific inhibitor for the K+ATP channel, caused vasoconstriction and restoration of blood pressure. Glyburide also induced vasoconstriction and restoration of blood pressure in the vasodilatory hypotension caused by hypoxic lactic acidosis, while it was ineffective in the hypotension induced by sodium nitroprusside. Thus, vasodilation and hypotension in septic shock are, at least in part, due to activation of the K+ATP channel in vascular smooth muscle, and anaerobic metabolism with acidosis is a sufficient stimulus for channel activation. Because anaerobic metabolism and acidosis are common features in shock of any etiology, sulfonylureas may be effective therapeutic agents in the treatment of shock.
内毒素血症会导致以血管舒张和对血管加压药产生抗性为特征的低血压。造成这些变化的分子机制尚不清楚。最近发现,ATP调节的钾离子(K⁺ATP)通道是血管平滑肌张力的重要调节因子,它可能将局部代谢变化转化为血管流量的改变。我们在此报告,在内毒素性低血压中,K⁺ATP通道的特异性抑制剂磺酰脲类药物格列本脲会引起血管收缩并使血压恢复正常。格列本脲在由缺氧性乳酸性酸中毒引起的血管舒张性低血压中也能诱导血管收缩并使血压恢复正常,而在硝普钠诱导的低血压中则无效。因此,脓毒性休克中的血管舒张和低血压至少部分是由于血管平滑肌中K⁺ATP通道的激活,而伴有酸中毒的无氧代谢是通道激活的充分刺激因素。由于无氧代谢和酸中毒是任何病因引起的休克的共同特征,磺酰脲类药物可能是治疗休克的有效治疗药物。